key: cord-0859355-4wsl06ym
authors: Kostoff, Ronald Neil; Briggs, Michael Brandon; Kanduc, Darja; Shores, Darla Roye; Kovatsi, Leda; Vardavas, Alexander I.; Porter, Alan L.
title: Common contributing factors to COVID-19 and inflammatory bowel disease
date: 2021-08-31
journal: Toxicol Rep
DOI: 10.1016/j.toxrep.2021.08.007
sha: 5658348166722e5393db263df5e06c1b3c496e99
doc_id: 859355
cord_uid: 4wsl06ym

The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual’s dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune system dysfunction. SARS-CoV-2 exploits the dysfunctional immune system to trigger a chain of events ultimately leading to COVID-19. We have previously identified many contributing factors (CFs) (representing toxic exposure, lifestyle factors and psychosocial stressors) common to myriad chronic diseases. We hypothesized significant overlap between CFs associated with COVID-19 and inflammatory bowel disease (IBD), because of the strong role immune dysfunction plays in each disease. A streamlined dot-product approach was used to identify potential CFs to COVID-19 and IBD. Of the fifty CFs to COVID-19 that were validated for demonstration purposes, approximately half had direct impact on COVID-19 (the CF and COVID-19 were mentioned in the same record; i.e., CF---→COVID-19), and the other half had indirect impact. The nascent character of the COVID-19 core literature (∼ one year old) did not allow sufficient time for the direct impacts of many CFs on COVID-19 to be identified. Therefore, an immune system dysfunction (ID) literature directly related to the COVID-19 core literature was used to augment the COVID-19 core literature and provide the remaining CFs that impacted COVID-19 indirectly (i.e., CF---→immune system dysfunction---→COVID-19). Approximately 13000 potential CFs for myriad diseases (obtained from government and university toxic substance lists) served as the starting point for the dot-product identification process. These phrases were intersected (dot-product) with phrases extracted from a PubMed-derived IBD core literature, a nascent COVID-19 core literature, and the COVID-19-related immune system dysfunction (ID) core literature to identify common ID/COVID-19 and IBD CFs. Approximately 3000 potential CFs common to both ID and IBD, almost 2300 potential CFs common to ID and COVID-19, and over 1900 potential CFs common to IBD and COVID-19 were identified. As proof of concept, we validated fifty of these ∼3000 overlapping ID/IBD candidate CFs with biologic plausibility. We further validated 24 of the fifty as common CFs in the IBD and nascent COVID-19 core literatures. This significant finding demonstrated that the CFs indirectly related to COVID-19 -- identified with use of the immune system dysfunction literature -- are strong candidates to emerge eventually as CFs directly related to COVID-19. As discussed in the main text, many more CFs common to all these core literatures could be identified and validated. ID and IBD share many common risk/contributing factors, including behaviors and toxic exposures that impair immune function. A key component to immune system health is removal of those factors that contribute to immune system dysfunction in the first place. This requires a paradigm shift from traditional Western medicine, which often focuses on treatment, rather than prevention.

The present study aims to demonstrate commonality between the contributing factors (CFs) to COVID-19 and Inflammatory Bowel Disease (IBD), and show that the bases for these superficially different diseases have important similarities. Much of the underlying motivation for this study has been presented previously [1] , and will not be repeated here.

The virus associated most closely with COVID-19 (SARS-CoV-2) is transmissible.

Whether serious consequences occur from this transmission depends on the health of the host's immune system [2] [3] [4] . In our model, these serious consequences of COVID-19 result from the effective exploitation of a dysfunctional immune system by the SARS-CoV-2 virus. In this exploitive process, genetic disposition and real-life exposures to multiple toxic stressors, and toxic behaviors, lay the ground work for immune system dysfunction [5] . Following SARS-CoV-2 exposure, the dysfunctional immune system is unable to neutralize the SARS-CoV-2 virus, thereby allowing the virus to enter and replicate in the cell and trigger a chain of events ultimately leading to COVID-19 [2] [3] .

If immune system dysfunction is a/the major factor in the severity of both infectious and chronic diseases, then a necessary, but not necessarily sufficient, condition for prevention and successful longstanding treatment is elimination of those factors that contribute to the dysfunction of the immune system. The virology-centric approach used currently for COVID-19 reflects damage control for a dysfunctional immune system (e.g., quarantine, face masks, vaccines, anti-viral treatments, etc.). A toxicology-centric approach would be aimed at identifying and removing the CFs to immune system dysfunctionality, whose evidentiary basis would require going beyond current singlestressor laboratory experiments to more comprehensive stressor combination experiments [2, 6] . We hypothesize that COVID-19 and IBD (a chronic inflammatory disease associated with immune dysfunction) share similar CFs.

J o u r n a l P r e -p r o o f augment identification of potential CFs to COVID-19. Since we identified the CFs related indirectly to COVID-19 prior to identifying the CFs related directly to COVID-19, this means our approach was effective for identifying potential direct impact CFs. The ability to identify potential direct impact CFs from the identification of indirect impact CFs can be exploited to initiate new research projects to confirm the transmutation of indirect impact CFs to direct impact CFs, and should be of high interest to researchers, research managers, research sponsors, and venture capitalists.

Third is the demonstration that the direct and indirect CFs to overlapped with the direct CFs to IBD.

This extensive overlap means that 1) many (if not most) of the causes for both diseases are similar, 2) any methods for prevention would have to be similar, and 3) at least some (if not many/all) methods for reversal would have to overlap.

That is a result/conclusion of the highest significance and has profound significance for how both types of disease are treated/prevented.

Given that the present approach to controlling the pandemic is essentially virologybased, with essentially no component addressing the toxicology, there is a major mismatch between what is needed to control the pandemic and what is being done.

J o u r n a l P r e -p r o o f

Background Our group has been developing protocols to prevent and reverse chronic diseases [7] [8] . The central component of our approach is identification and elimination of CFs to these myriad chronic diseases. The question arises: can our toxicology-based approach for preventing and reversing chronic diseases be integrated successfully with the present virology-based approach to preventing and reversing communicable diseases that exploit immune system dysfunction, such as COVID-19? Before we demonstrate our integrated virology-toxicology approach for IBD-COVID-19, we present a brief summary of the key components: COVID-19, IBD, Toxicology.

Over the past two decades, there have been at least three major coronavirus-based infectious disease outbreaks/epidemics/pandemics: Severe Acute Respiratory Syndrome inflammation/damage. Another important similarity among these infectious diseases is the demographic affected most severely: the elderly and others who have comorbidities associated with dysfunctional immune systems [1, [9] [10] [11] [12] [13] .

IBD is a spectrum of chronic inflammatory gastrointestinal (GI) disorders, most commonly categorized as Crohn's disease (CD) and ulcerative colitis (UC) [14] . The incidence of IBD is rising in industrialized countries and in children, suggesting exposures

to CFs are at play [15] [16] . The pathogenesis of IBD is multifactorial. While multiple genes associated with dysregulation of both innate and adaptive immunity have been identified, environmental factors, including diet, infection, and toxin exposure that alter the intestinal J o u r n a l P r e -p r o o f microbiome, also trigger epigenetic alterations in immune regulation [17] [18] . Treatment often includes immunosuppressive therapy, which may increase the risk of serious infection. Of particular interest, a large international registry from 49 countries of patients with IBD has found that those patients treated with biologics, such as anti-tumor necrosis factor, had lower rates of severe COVID-19 [19] . It was postulated that biologic therapies suppress the cytokine storm associated with severe COVID-19. The same protection was not seen with other immunosuppressive medications, including thiopurines and corticosteroids [19] .

In its broadest sense, toxicology is the study of the impact that toxic stimuli and toxic behaviors, and their combinations, can have on all members of the animal kingdom and their environment. Its two most important components are epidemiological-type studies to identify potential adverse effects of candidate toxic stimuli and behaviors, and laboratory studies to identify mechanisms that link the stimuli to their adverse effects.

The toxic stimuli/behavior exposures can range from acute to chronic, and the doses can span a wide spectrum.

Toxicological components constitute the bulk of modifiable CFs responsible for IBD and COVID-19. The toxicological components included in the present study cover toxic lifestyles (diet, activity, sleep, substance abuse, etc.), medical procedures (drugs, diagnostics, surgery, non-drug therapies, etc.), bio-organisms (fungi, mold, parasites, viruses, bacteria, etc.), environments, occupations, psychosocial events, and socioeconomic environments. The laboratory-based evidence for the toxicity of most toxic substances is obtained through single-stressor laboratory experiments, which underrepresent real-world effects. Combinations of toxic stimuli reflect real-world exposures, and doses of substances that can cause damage in combinations are lower than doses that can cause damage in single-stressor experiments of those substances [6] . Each of these factors play a key role in such chronic exposure paradigms, revealing the importance of J o u r n a l P r e -p r o o f required further toxic evaluations so as to discover possible routes that would eventually lead to a human risk and even to a specific link between an epidemic and a disease.

The rapidly growing body of scientific evidence on COVID-19 indicates that in order for a patient to exhibit serious symptoms and side-effects, an underlying dysfunction of the immune system is necessary. Different factors, among which is the genetic disposition, as well as the exposure to toxic stimuli, aid the virus in rendering the immune system vulnerable [5] .

Our results address a wide range of toxic stimuli; a couple that have wide impact are mentioned here briefly. One of the toxic stimuli that plays an important role seems to be excessive alcohol consumption. Recent work implies that it affects the immune system in a way that renders it more vulnerable to SARS-CoV-2 virus infection and that the underlying mechanism includes the reduction of T lymphocytes, the increase of proinflammatory cytokines, the diminished function and number of natural killer cells and the inadequate function of the macrophages [20] . It has also been proposed that chronic ethanol consumption leads to malnutrition and lack of micronutrients that are necessary for the normal function of the immune system [21] .

Another toxic stimulus that is attracting attention (as to its implication in SARS-CoV-2 virus infection susceptibility) is smoking. Because of conflicting evidence of smoking impact on both IBD and COVID-19, it was not included as a CF in our results, but is addressed in detail in the Discussion section.

Overview A credible identification of CFs common to two diseases (such as IBD and COVID- 19) based on their core literatures depends on three major criteria: the relative size Because of the discrepancy in size between the IBD core literature (~75,000 records) and

the ID core literature, we expected that IBD/ID overlaps would be limited by the potential CFs in the IBD literature, which in fact was the result. We determined commonality between CFs to IBD and COVID-19 using a streamlined dot-product approach (intersection of phrase lists) and we identified modifiable factors that contribute to both IBD and COVID-19.

Thematic differences between ID and COVID-19 core literatures

The metrics used to evaluate thematic differences between the core ID and COVID-19 literatures were the main specific biomarkers and the abnormalities of their values. We examined the main specific biomarkers exhibiting abnormalities in the COVID-19 core literature, and found strong overlap with the main specific biomarkers in the ID literature.

J o u r n a l P r e -p r o o f 

In 2014, the first author published a study showing theme commonalities between Parkinson's Disease (PD) (neurodegenerative) and Crohn's Disease (autoimmune) using phrase matching and bibliographic coupling (shared references) between the two disease literatures [23] . Because of the strong emphasis on shared references, the commonality of PD and CD at a more fundamental mechanism level was demonstrated. Combining these two approaches for identifying commonality (CF commonality and bibliographic coupling/phrase matching) could provide deeper understanding at different levels of commonality between IBD and ID/COVID-19.

The streamlined method used for this study is termed a dot-product approach [1] .

Lists of known toxic substances were aggregated from myriad (mainly) government agencies, and combined with lists of CFs identified in our previous disease studies. This produced a final database of approximately 13000 potential CFs to disease. While this is certainly a large number of potential CFs, it undoubtedly omits additional CFs that a wellresourced study could have identified.

A core literature query was defined for IBD, applied to PubMed, and the resultant retrieval (~75000 records with abstracts, covering 1990-2020) was imported into VantagePoint (VP) software (www.theVantagePoint.com). The title and abstract phrases of the retrieved records were parsed, resulting in lists of many phrases. The same procedure was followed for the ID core literature (~202000 records with abstracts, covering 1990-2020), and for the COVID-19 core literature (~54000 records with abstracts, covering 1 December 2019-mid-December 2020, and periodically updated to include about 84,000 records by the end of March 2021).

The external list of ~13000 phrases of potential CFs was intersected with the parsed list of abstract phrases in the IBD, ID, and COVID-19 core literatures to generate the subset of the ~13000 phrases relevant to each core literature. There were ~3100 candidate IBD CFs, ~6500 candidate ID CFs, and ~2400 candidate COVID-19 CFs (candidate means they are potential CFs, but need to be validated as actual CFs). These intersected lists were compared, and the candidate CFs in common between IBD and ID were identified initially. When the decision was made to include CFs that directly impacted COVID-19, then the candidate CFs in common between IBD and COVID-19, and ID and COVID-19, were identified. Approximately 3000 candidate CFs in common between IBD and ID, 1900

candidate CFs in common between IBD and COVID-19, and 2300 candidate CFs in common between ID and COVID-19 were identified, albeit some being variants of the same concept.

These CF commonalities are displayed graphically in Figure 1 Finally, the CFs common among all three diseases (ID-IBD-COV) are limited by, and essentially identical to, the IBD-COV commonality. This is to be expected, given that ID-J o u r n a l P r e -p r o o f IBD and ID-COV commonalities were limited by (and almost identical to) the number of IBD and COV CFs, not by numbers of ID CFs. However, this is a very conservative estimate of candidate CFs in common for both comparisons, for the reasons presented in the next section.

First, only CFs that occurred within the IBD and ID core literatures (direct impact CFs), or within the IBD and COVID-19 core literatures, were used for the dot-product.

Thus, if a candidate CF was shown to enhance oxidative stress, and enhanced oxidative stress was a marker of IBD or ID, or of IBD or COVID-19, the candidate CF became a confirmed direct impact CF if the article that showed the linkage to CF was in the IBD or ID core literature, or the IBD or COVID-19 literature, respectively. If the candidate CF enhanced, say, "oxidative stress," but the article(s) that showed this linkage was not in the IBD or ID core literature, or the IBD or COVID-19 core literature, then the candidate CF did not become a validated direct impact CF. Given that "oxidative stress" occurs in about 800 abstracts in the IBD literature used for the present study, and about 230000 abstracts in the total Medline database, these indirect impacts that require merging of two records (impact of CF on oxidative stress; impact of oxidative stress on IBD) have the potential to expand the number of records in common substantially. If indirect impacts, as defined above, had been included, much larger numbers of both CFs and commonalities would have resulted [1] .

Second, all the matching and dot-product operations required exact phrase matching.

The slightest difference between any two phrases meant neither phrase survived the dotproduct process. Given the disagreements on phrase representations among the toxic substance list providers for identical concepts, especially chemical formulas, and the subsequent disagreements between the external phrases and the parsed phrases of the PubMed retrievals, we estimate many hundreds (or more) of phrases in common were lost. The fact that ~3000 common IBD and ID phrases, and ~1900 common IBD and COVID-19 phrases, survived is testament to the potentially large commonality between J o u r n a l P r e -p r o o f the CFs to IBD and COVID-19. We would expect similar results between COVID-19 and most (if not all) chronic diseases, based on the findings in our Pervasive Causes of Disease eBook [1, 24] .

Third, as has been shown in past studies [6, [25] [26] [27] , there are myriad substances and radiation forms that, at specified dosages, exhibit toxic effects only when combined with other toxic substances and radiation forms. Most of these low-dose CFs would not be identified in laboratory experiments, since the laboratory experiments tend to focus on single stressor results. If such combination laboratory experiments were to be performed, we would expect the number of CFs to increase substantially, given the total number of combinations possible [6] .

Fourth, in order for a toxic substance or behavior to have been included in the core literature for IBD or ID or COVID-19, it had to have been researched and reported in

Medline. Given the large number of potentially toxic substances and behaviors possible [24] , and the limited number of biomarkers used in experiments to identify their adverse effects, the number of toxic combinations studied is severely limited [25] . Therefore, the number of potential CFs that enter any disease core literature is also limited [1] .

Additionally, there are many types of documentation other than journals indexed in Medline (or the Science Citation Index), such as books, Web documents, less-wellknown indexing services, more obscure journals, etc. This also would limit CFs accessible to the present study, which focused mainly on Medline records.

The phrases in common between IBD and ID, and between IBD and COVID-19, should be viewed as candidate CFs, which must be validated as actual CFs by detailed analysis. How many validated CFs are required to support the hypothesis of common causation between the two diseases? There are two main criteria to be considered in making the selection. The first criterion is numbers of CFs in common. The second criterion is the importance of the CFs in contributing to the disease.

If, as in many large and complex systems, the system operation is determined mainly by a few significant factors, then a handful of such significant factors is all that would be required to support our hypothesis. If no such significant factors stand out, then more CFs would be required to support the hypothesis of common cause.

For IBD and ID, there were significant factors that stood out, and these were the foundation of the validation selection process. A balance/tradeoff between the two major selection criteria resulted in the selection of fifty common phrases between IBD and ID to be validated as CFs. These fifty included those deemed most significant and spanning the five-category taxonomy we have developed for classifying modifiable CFs to disease:

Lifestyle, Iatrogenic, Biotoxins, Occupational/Environmental, Psychosocial/ SocioEconomic [7] . We did not include Genetics, since the CFs in our definition are viewed as modifiable, meaning they are somewhat under our control.

After the fifty CFs common to IBD and ID had been selected and validated, we decided to ascertain which of them were valid COVID-19 direct impact CFs and thereby also common with IBD J o u r n a l P r e -p r o o f

The fifty CFs in common between IBD and ID selected for validation, as well as the 24 direct impact CFs in common between IBD and COVID-19, are presented in Table 1 .

The detailed record excerpts showing these linkages are presented in Appendix 1. Table   2 shows the strong emphasis on immune system biomarkers, mainly inflammation-centric with some emphasis on oxidative stress biomarkers.

The results show conclusively the wide range of CFs in common between IBD and ID. Most importantly, the implication of the results is that strengthening the immune system against both infection and autoimmune diseases requires the discipline to 1) remove exposure to a broad range of toxic substances and 2) eliminate toxic behaviors.

Special mention should be made of cigarette smoking. It was identified as a candidate CF in the analysis, but was not included in Table 1 because of conflicting information relative to its UC impact and its COVID-19 impact. Because of its importance, however, it will be addressed in detail here.

The association between cigarette smoking and IBD is complex. In our literature search, terms related to smoking, IBD, and COVID-19 returned 10-100-fold higher matches than other potential CFs. Cigarette smoking (both current and former use) remains the strongest environmental risk factor associated with developing CD in Western countries, and portends a more severe disease course compared to non-smokers [28] . Interestingly, current smoking is inversely related to developing UC in some studies, and smoking cessation has been associated with subsequently developing UC [29, 30] . However, regular smoking that begins at a young age (10 years) is associated with a higher risk of developing UC [31] . Maternal smoking and passive smoke exposure in childhood is associated with developing CD [30, 31] .

Smoking likely influences intestinal inflammation through multiple mechanisms,

given the numerous compounds found in tobacco, and individual genetic and epigenetic susceptibility [32, 33] . Cigarette smoke can 1) negatively impact tight junctions and intestinal barrier function, allowing for increased intestinal permeability and translocation; 2)

interfere with Paneth cell function, reducing antimicrobial peptide release and clearance of pathogens; 3) induce epithelial oxidative damage; and 4) contribute to dysbiosis [32] .

Smoking also directly affects the immune system by modulating Th-1 response, clonal expansion of CD8+ and Th17 cells, and pro-inflammatory cytokine release [32] .

Nicotine may have a positive impact on mucus production and adhesion molecule expression, though clinical trials with smoking and nicotine have had mixed results without a clear benefit in the treatment of UC due to side effects [32] [33] [34] [35] . It is well-established that smoking contributes to lung dysfunction, and a recent meta-analysis confirms that smoking is associated with the severe COVID-19 disease progression [36] .

To date, the available information is somewhat controversial. The World Health Organization (WHO) recently confirmed that smokers are at greater risk of severe complications following SARS-CoV-2 virus infection, compared to non-smokers [37] .

On the other hand, the known anti-inflammatory properties of nicotine have been suggested as a possible explanation for the low smoking prevalence in hospitalized patients in China [38] .

Among the many contributing factors that are common to ID and IBD, and that can Glycation End products (RAGE) [39] [40] [41] [42] [43] . By binding to RAGE on the cell surface, AGEs trigger the release of pro-inflammatory tumor necrosis factor-alpha (TNF-α) [44] , the proinflammatory cytokine that has a pathological role in IBD [45, 46] . Moreover, TNF-α sustains the progression of IBD by promoting the expression of the pro-inflammatory interleukins IL-1β, IL-6, and IL-33 [46, 47] . RAGE can also bind S100A8 and S100A9, two proteins predominantly found as calprotectin (S100A8/A9) and involved in inflammatory processes and immune response [48] . Binding of calprotectin (S100A8/A9) to RAGE results in significantly increased secretion of pro-inflammatory interleukin (IL)-6, IL-8, IL-1β, and TNF-α [49] , thus leading to a further amplification of the pro-inflammatory cascade.

Moreover, in a positive feedback loop, the AGEs-induced/upregulated RAGE can mediate gene expression of S100A8 and S100A9 [50] .

Calprotectin is involved in the regulation of the NLRP3 inflammasome [51] that is directly implicated in IBD [52] , and is one of the most useful tools for monitoring intestinal inflammation for clinical management of IBD [53] .

The disintegrated immunological scenario that links AGEs to IBD also characterizes the relationship between High Fat Diets (HFDs) and IBD. HFDs have been repeatedly related to IBD [54, 55] , most possibly because of the fatty acids capacity of inducing a systemic chronic low-grade inflammation [56] marked by elevated production of the proinflammatory cytokines interleukin (IL)-1β [57, 58] , IL-6 [59] , and TNF-α [60] in the gut. The molecular basis underlying the pathological connection between HFDs and IBD appears to be the NLRP3 inflammasome [61] , with saturated fatty acids promoting NLRP3

inflammasome activation [62] and unsaturated fatty acids impeding NLRP3 activity [62, 63] .

Vitamin D deficiency has been reported to occur frequently in people with IBD [64] [65] [66] . Again, NLRP3 inflammasome activation appears to play a main role in the connection between Vitamin D deficiency and IBD. Indeed, Vitamin D exerts potent antiinflammatory effects [67] by enhancing the Vitamin D Receptor signaling that inhibits NLRP3 inflammasome activation and IL-1β secretion [68] .

On the whole, a molecular picture emerges that correlates different CFs to the etiology and chronicization of IBD. In addition, these CFs also relate to SARS-CoV-2

infection. In fact, as in IBD, the inflammation that characterizes COVID-19 is dominated by high cytokine levels (IL-2R, IL-6, IL-10, and TNF-α) [69] . Moreover, it has been proposed that RAGE and its ligands may play a pivotal role in COVID-19 pneumonia [70, 71] , particularly in the presence of concomitant comorbidities like diabetes mellitus [72] .

Clinically, data show that elevated calprotectin levels discriminate severe from mild COVID-19 [73] and correlate with inferior clinical outcomes [74] .

Of note, SARS-CoV ORF8b triggers NLRP3 inflammasome activation and IL-1β release by binding to the leucine rich repeat (LRR) domain of NLRP3, resulting in macrophage pyroptosis [75, 76] . Accordingly, inflammasome activation has been found in COVID-19 patients with cardiac involvement [77] and in the lungs of patients with fatal COVID-19 [78] .

In sum, IBD and COVID-19 share CFs able to induce immune dysfunctional disorders that have a minimum common denominator in NLRP3 inflammasome activation. Such commonality leads to theoretical predictions of an increase of IBD morbidity as a sequel of the current SARS-CoV-2 pandemic, particularly in those patients with IBD who have active inflammation.

We have presented the foundation for a unified theory of chronic-infectious disease from the perspectives of causation and prevention. As a result, our findings suggest a need for paradigmatic shift in medical approaches to disease. The current approach to both infectious and chronic disease in Western medicine is often external-treatment-based (i.e., providing a drug, vaccine, radiation, surgery, etc.) to reduce symptoms without sufficiently addressing the underlying modifiable factors that enabled the disease to emerge. This study highlights modifiable factors (toxic exposures and behaviors) that contribute to disease pathogenesis via various mechanisms of immune dysfunction, and J o u r n a l P r e -p r o o f shows commonality between IBD and COVID-19. Eliminating these factors as comprehensively and rapidly as possible is prudent, and should be pursued in parallel with treatment.

Kostoff RN contributed to this paper with conception, data analysis, and writing the manuscript; Briggs MB participated in data analysis, results validation, and table development; Kanduc D participated in data analysis and writing the manuscript; Shores DR contributed to query development, background development, and editing; Kovatsi L, Vardavas A, and Porter AL contributed to writing the manuscript and editing; all the authors approved the final version of the manuscript.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

J o u r n a l P r e -p r o o f [192] [193] Restraint stress 5 [194] [195] Sexual abuse 5 [196] [197]

J o u r n a l P r e -p r o o f APPENDIX 1

IBD: "This study demonstrates that the oral intake of AGEs promotes their accumulation in the GI tract, and AGEs attenuate the first-line antioxidant defence and stimulate the inflammatory response of the GI tract by downregulating enzymatic antioxidative pathways and increasing inflammatory cytokine levels." [79] ID: "Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages" [80] COV: "There are many features of diabetes and obesity that may accentuate the clinical response to SARS-CoV-2 infection: including an impaired immune response, an atherothrombotic state, accumulation of advanced glycation end products and a chronic inflammatory state." [81] Alcoholism IBD: "the AI [alcoholic intoxication] cohort exhibited a 3.17-fold increased risk of IBD compared with the non-AI cohort" [82] ID: "evidence that alcohol abuse is associated with significant zinc deficiency and immune dysfunction within the alveolar space" [83] COV: "We conclude that, from the available literature, the predictors of pulmonary cells" [85] ID: "Longitudinal transcriptomic profiling in carrageenan-induced rat hind paw peripheral inflammation and hyperalgesia reveals progressive recruitment of innate immune system components" [86] Consumer Antimicrobials IBD: "These results suggest that BAC [Benzalkonium Chloride] and BET

[BenzethoniumChloride]….. were able to increase DSS-induced colonic inflammation." [87] ID: "Immune cells and cytokinesplay critical roles in the development of colitis…..exposure toBAC and BET…..increased infiltration of immunecellsincluding leukocytes (CD45þ), macrophages (CD45þ, F4/80þ), and neutrophils (CD45þ, Gr1þ)-into colon tissues…..exposure to BAC andBET…..increased concentrations of interleukin 6(IL-6), a proinflammatory cytokine, in colonic explant…..qRT-PCR analysisshowed that exposure to BAC increased gene expression of Il-6in colon tissues" [87] High-Fat Diet IBD: "High-fat diet promotes experimental colitis by inducing oxidative stress in the colon" [88] ID: "these data suggest that HFD [High-Fat-Diet] promotes colitis by aggravating mucosal oxidative stress, which rapidly drives mucosal inflammation and increases intestinal mucosal barrier permeability" [89] COV: "Obesity is a medical condition with complex pathophysiology, comprising various mechanisms, which now emerges as a significant risk factor for COVID -19" [90] J o u r n a l P r e -p r o o f Findings of the colonoscopy revealed a pancolitis type of UC" [113] ID: "Cisplatin induced marked inhibition of cellular immunity as exhibited by significant decrease of leukocytic count, lymphocyte percentage and phagocytic activity with marked increase in neutrophil percentage. Humoral immunity represented by marked inhibition in total protein and γ-globulin concentration and significant inhibition in antibody titer against Mycoplasma gallisepticum were recorded" [114] J o u r n a l P r e -p r o o f IBD: "Prolonged morphine treatment results in a "leaky" gut, predisposing to colonic inflammation that is facilitated by microbial dysbiosis and associated bacterial translocation." [115] ID: "we show that morphine suppresses the innate immunity in microglia and bone marrow-derived macrophages through differential regulation of TLRs and acetylcholinesterase. Either morphine or inhibition of acetylcholine significantly promotes upregulation of microRNA-124 (miR-124) in microglia, bone marrowderived macrophages, and the mouse brain, where miR-124 mediates morphine inhibition of the innate immunity by directly targeting a subunit of NF-κB p65 and TNFR-associated factor 6 (TRAF6)." [116] COV: "Substance use disorders can also increase the risk of adverse COVID-19 outcomes through immunosuppression…..For example, opioids exert various suppressive effects on both the innate and adaptive immune systems, especially among those who have long used substances (>=90 days in a year). Largely by binding to the mu receptor and modulating various downstream cellular signaling pathways, opioids impair the recruitment and function of virtually all immune cells, such as macrophages, NK cells, granulocytes, and B and T lymphocytes" [117] Oral Contraceptives IBD: "This study provides evidence of an association between the use of oral contraceptives and the onset risk of UC" [118] ID: "17α-ethinyl estradiol (EE), a synthetic analog of 17β-estradiol, is prescribed commonly and found in oral contraceptives and hormone replacement therapies.

Surprisingly, few studies have investigated the immunoregulatory effects of exposure to EE, especially in autoimmunity….. EE-exposed mice had increased proteinuria as early as 7 weeks of age. Proteinuria, blood urea nitrogen, and glomerular immune complex deposition were also exacerbated when compared to J o u r n a l P r e -p r o o f controls. Production of cytokines by splenic leukocytes were altered in EE-exposed mice. Our study shows that oral exposure to EE, even at a very low dose, can exacerbate azotemia, increase clinical markers of renal disease, enhance glomerular immune complex deposition, and modulate TLR7/9 cytokine production in female MRL/lprmice" [119] Radiotherapy IBD: "Fifty percent of patients develop chronic gastrointestinal (GI) symptoms following pelvic radiotherapy that adversely affect quality of life." [120] ID: "Systemic responses to radiation detected at the blood proteome and metabolome levels are primarily related to the intensity of radiation-induced toxicity, including inflammatory responses" [121] COV: "The results of the current study demonstrated a possible association between recent receipt of oncologic treatment and a higher risk of death among patients with carcinoma who are hospitalized with COVID-19." [122] Renal Transplantation IBD: "patients after kidney transplantation have significant risk of gastrointestinal pathologies and require detailed diagnostic endoscopy" [123] ID: "Immunosuppressive therapy causes severe impairment of host defense and diarrhea is a frequent complication in renal transplant recipients." [124] COV: "Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and

RT patients than in the general population." [125] Rituximab J o u r n a l P r e -p r o o f IBD: "There are reports of rituximab-associated ulcerative colitis; however, we report for the first time, two cases of rituximab-induced Crohn's disease in elderly patients treated for lymphoma." [126] ID: "Following rituximab administration, worsening hypogammaglobulinemia was noted. There was an increase in severe infections after rituximab use in the study cohort" [127] COV: "High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study" [128] Vaccines IBD: "receiving seven vaccines or more during childhood increased the risk of developing inflammatory bowel disease by nine-fold (odds ratio = 9.2, confidence interval = 2.9-29.4)" [129] ID: "We randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo. Over the following 9 months, TIV recipients had an increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95%

confidence interval: 1.31-14.8). Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses." [130] CATEGORY 3 -BIOTOXINS Zearalenone IBD: "Changes in Th1 and Th2 cytokine concentrations in ileal Peyer's patches in gilts exposed to zearalenone" [138] ID: "Changes in Th1 and Th2 cytokine concentrations in ileal Peyer's patches in gilts exposed to zearalenone" [138] COV: "Even within a single city, higher levels of air pollution are associated with an adverse impact on COVID-19 risk." [141] Aluminum repair strongly suggest that aluminum might be an environmental IBD risk factor." [142] ID: "studies in the literature showed that Al decreased splenic iron (Fe) and zinc (Zn) levels, but the effects of Al on splenic copper (Cu) level was ambiguous and controversial. Al exposure inhibited levels of ANAE(+) cells, the production of interleukin (IL)-2 and the functions of macrophages. With respect to other key cytokines, studies showed that Al suppressed the production of tumor necrosis factor (TNF)-α in vitro; effects of Al on TNF-α formation in vivo were less overt. Al exposure reduced complement 3 (C3) level," [143] Benzene IBD: "TNBS colitis increased epithelial barrier permeability in-vitro and in-vivo. Colonic IL-1β concentrations, colonic and systemic CD11b+ cell infiltration, and the number of migrating CD11b+ cells on colonic blood vessels were all increased in TNBS treated mice relative to controls. CMMC frequency and amplitude were inhibited in the distal and mid colon of TNBS treated mice." [144] J o u r n a l P r e -p r o o f ID: "reduced ALA-D activity, decreased CD80 and CD86 expression in monocytes and increased IL-8 levels were found in the GSA group compared to the control subjects. Furthermore, according to multiple linear regression analysis, benzene exposure was associated to a decrease in CD80 and CD86 expression in monocytes." [145] COV: "The airborne benzene concentration was the leading risk factor in 24% of the counties" [146] Benzo(A)Pyrene IBD: "BaP oral exposure significantly altered the composition and the abundance of the gut microbiota and led to moderate inflammation in ileal and colonic mucosa." [147] ID: "Exposure of fish to BaP resulted in a significant decrease of total RBC and WBC, lysozyme activity, lysosomal membrane stability, IgM level and antibacterial activity after 4 days and phagocytosis after 7 days of the experiment (P < 0.05).

Totally, the results revealed BaP ability to suppress the fish immune function." [148] Bisphenol IBD: "Oral exposure to bisphenols induced food intolerance and colitis in vivo by modulating immune response in adult mice" [149] ID: "Perinatal oral exposure to low doses of bisphenol A, S or F impairs immune functions at intestinal and systemic levels in female offspring mice" [150] COV: "this paper focuses on the potential role of BPA in promoting comorbidities associated with severe COVID-19, as well as on potential BPA-induced effects on key SARS-CoV-2 infection mediators, such as angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2)…..BPA exposure may impact on the local expression of these SARS-CoV-2 infection mediators. Overall, the potential role of BPA on the risk and severity of COVID-19 merits further investigation." [151] J o u r n a l P r e -p r o o f CdCl2 tended to enhance intestinal inflammation in mice." [152] ID: "Functional endpoints tumour necrosis factor-alpha and nitrite production in lipopolysaccharide-activated macrophages were increased by cadmium exposure.

In contrast, mast cell lipopolysaccharide-induced tumour necrosis factor-alpha and IgE-mediated histamine release were reduced by cadmium. These data indicate potentially differential effects of cadmium among murine innate immune cell types, where mast cells would be more susceptible to oxidative stress and their function might be at a higher risk to be modulated compared to macrophages." [153] COV: "The existing data demonstrate that As, Cd, Hg, and Pb exposure is associated with respiratory dysfunction and respiratory diseases (COPD, bronchitis). These observations corroborate laboratory findings on the role of heavy metal exposure in impaired mucociliary clearance, reduced barrier function, airway inflammation, oxidative stress, and apoptosis. The association between heavy metal exposure and severity of viral diseases, including influenza and respiratory syncytial virus has been also demonstrated. The latter may be considered a consequence of adverse effects of metal exposure on adaptive immunity. Therefore, reduction of toxic metal exposure may be considered as a potential tool for reducing susceptibility and severity of viral diseases affecting the respiratory system, including COVID-19." [154] Chlorpyrifos IBD: "dietary exposure to CPF aggravated tissue injuries in mice with DSS-induced chronic colitis by suppressing T-cell populations and Treg polarization." [155] ID: "CPF-induced ROS regulates immune response by stimulating the antigenpresenting ability of head kidney in carp." [156] J o u r n a l P r e -p r o o f

IBD: "exposure to fluoride seems indirectly associated with higher incidence of IBD ...

Epidemiological studies suggest an association between fluoride exposure and IBD" [157] ID: "sodium fluoride (NaF) treatment of rats by gavage for 28 days resulted in the induction of oxidative stress and immunotoxicity… NaF treatment lowered cellular immunity in the rats as illustrated by a significant diminution in peripheral blood lymphocyte, monocyte and neutrophil counts in conjunction with a reduction in splenocyte counts. Effects of NaF treatment on humoral immunity were reflected here in a lowering of the levels of plasma IgG specific to a test antigen (i.e., bovine serum albumin). Disorganization in the histoarchitecture was also noted in the host spleen and thymus after NaF treatment." [158] Mercury IBD: "In a patient with chronic ulcerative colitis in remission, occupational exposure to mercury vapor led to episodes of disease reactivation." [159] ID: "Significantly increased IgE levels was found in the mercury-exposed individuals. ... These results suggest that the humoral immune response is an indicator of cellular changes in workers chronically exposed to mercury, even in those with urinary mercury concentrations within levels considered safe in the occupational area." [160] COV: "The existing data demonstrate that As, Cd, Hg, and Pb exposure is associated with respiratory dysfunction and respiratory diseases (COPD, bronchitis)…..reduction of toxic metal exposure may be considered as a potential tool for reducing susceptibility and severity of viral diseases affecting the respiratory system, including COVID-19." [154] Microplastics J o u r n a l P r e -p r o o f [161] ID: "nano-and microplastic exposure disturbs the gut microbiota and critical intestinal functions. Such effects may promote the development of chronic immune disorders" [161] Nickel IBD: "demonstrates that UC patients have a significantly higher incidence of hypersensitivity to nickel and palladium, suggesting the possible involvement of dental metal hypersensitivity in UC pathogenesis." [162] ID: "Ni toxicity also induces inflammation and several studies demonstrated that Ni could induce immunotoxicity. Excessive Ni exposure can inhibit the development of immune organs by excessively inducing apoptosis and inhibiting proliferation.

Furthermore, Ni can decrease T and B lymphocytes, ... Ni inhibits the production of cytokines in non-inflammatory responses. Cytokine levels increased in Niinduced inflammation responses, and Ni activates inflammation through toll like (TL)4-mediated nuclear factor-κB (NF-κB) and signal transduction cascades mitogen-activated protein kinase (MAPK) pathways. Ni has been indicated to inactivate NK cells and macrophages both in vitro and in vivo." [163] J o u r n a l P r e -p r o o f ID: "This study demonstrates that PFOA can affect IL expression level through NF-κB, and ILs have an important function in the mediation of Ig secretion." [169] COV: "Measures of individual exposures to immunotoxic PFASs included short-chain PFBA known to accumulate in the lungs. Elevated plasma-PFBA concentrations were associated with an increased risk of a more severe course of COVID-19." [170] PAH (Polycyclic Aromatic Hydrocarbons)

IBD: "Nicotine, nitrosamines, and polycyclic aromatic hydrocarbons included in tobacco smoke are major causative agents of tobacco smoking-related alimentary diseases.

These agents have harmful effects on digestive organ through compromised blood circulation, impaired neural regulation, and cell dysfunction. These malfunctions cause tissue destruction, such as chronic inflammation and ulcer formation. Besides forming DNA adducts, they also act on endogenous signal transduction, leading to gene mutation and abnormal cell death and growth. Interestingly, in inflammatory diseases, smoking improves symptoms of ulcerative colitis, while it worsens the condition of Crohn diseases" [171] ID: "Ten polycyclic aromatic hydrocarbons were evaluated following 14 days of subchronic exposure in female B6C3F1 mice. ... The immunosuppression observed following both subchronic and acute exposure was similar to the structure-activity relationship observed for the carcinogenicity of the compounds tested. ...

Benz(a)anthracene, benzo(a)pyrene, dibenz(a,c)anthracene, and dibenz(a,h)anthracene suppressed the antibody-forming cell response by 55 to 91%. The greatest suppression was observed with the 3-methylcholanthrene and 7,12,-dimethylbenz(a)anthracene." [172] COV: "polycyclic aromatic hydrocarbons (PAHs) are among the outdoor air pollutants Silica Dust IBD: "Silica dust exposure correlates with an increased risk of developing UC, especially in men, and the risk seems to increase with the duration and degree of exposure.

Conversely, silica dust exposure correlates positively with the risk of developing CD in women." [174] ID: "Silica dust exposure induces autophagy in alveolar macrophages through switching Beclin1 affinity from Bcl-2 to PIK3C3" [175] COV: "Mineworkers continue to experience high levels of silica exposure. The prevalences of silicosis, HIV and pulmonary TB, remain high. Interstitial lung disease, pulmonary TB, and HIV have all been associated with poorer outcomes of SARS-CoV-2 infections." [176] Sodium Dichromate Dihydrate IBD: "In summary, administration of sodium dichromate dihydrate in the drinking water to F344/N rats and B6C3F1 mice resulted in focal ulceration, hyperplasia, and metaplasia in the glandular stomach at the limiting ridge in rats in the 1,000 mg/L group and evidence of increased histiocytic infiltration in the liver (female), duodenum of the small intestine, and/or pancreatic lymph nodes at concentrations as low as 62.5 mg/L" [177] ID: "respiratory defence and immunologic functions were stimulated or inhibited depending on dose and time of chromium (VI) inhalation" [178] COV: "Urinary concentrations of chromium, manganese, copper, selenium, cadmium, mercury and lead after creatinine adjustment were found to be higher in severe J o u r n a l P r e -p r o o f patients than the non-severe cases with COVID-19. ... These results suggest abnormities in urinary levels of the trace metals were tightly associated with the severe illness and fatal outcome of COVID-19." [179] Titanium Dioxide IBD: "Our data provide support that TiO2 NP ingestion alters the GI microbiota and host defenses promoting metabolic disruption and subsequently weight gain in mice." [180] ID: "Our data suggest that TiO2 nanostructural materials suppress splenocytes proliferation by suppressing Th1 cytokines." [181] Triclocarban IBD: "exposure to low-dose TCC exaggerated the severity of colitis. … via gut microbiota-dependent mechanisms. Exposure to TCC increased dextran sodium sulfate (DSS)-and interleukin 10 (IL-10) knockout-induced colitis" [182] ID: "A significant induction of concentrations of proinflammatory mediator and nitric oxide (NO), accompanied by an upregulated expression of inducible NO synthase gene, was detected in zebrafish embryos exposed to TCC. The transcription of immune-response-related genes, including tnf-α, il-1β, il-4, il-8, and cxcl-clc, was significantly upregulated on exposure to TCC. Furthermore, we found that the exposure of zebrafish embryos to TCC decreased immune cell recruiting in the head. Expressions of nf-κb, trif, myd88, irak4, and traf6 were altered on exposure to TCC. These results demonstrated that exposure to TCC at environmental concentrations significantly affects the expression of immune-response-related genes in zebrafish embryos following oxidative stress and the release of proinflammatory mediators through Toll-like receptor signaling pathway." [183] Turpentine J o u r n a l P r e -p r o o f IBD: "The effects of an intrathecal NMDA antagonist (AP5) on the behavioral changes induced by colorectal inflammation with turpentine in rats" [184] ID: "Modified immunoglobulin G glycosylation pattern during turpentine-induced acute inflammation in rats" [ ID: "For the 12-mo vaccination alone, the relative incidence of events (95% CI) on days 4 to 12 following immunization was 1.35 (1.31 to 1.38). We observed a significant relationship between socioeconomic status [SES] and vaccination at 12 mo, with lower SES being associated with a higher relative incidence of events (p = 0.0075)." [187] COV: "By means of individual-level survival analysis we demonstrate that being male, having less individual income, lower education, not being married all independently predict a higher risk of death from COVID-19 and from all other causes of death." [188] Posttraumatic Stress IBD: "autoimmune disorders, including thyroiditis, inflammatory bowel disease, ...

Trauma exposure and PTSD may increase risk for autoimmune disorders. Altered J o u r n a l P r e -p r o o f immune function, lifestyle factors, or shared etiology may underlie this association." [189] ID: "Altered gene expression of the innate immune, neuroendocrine, and nuclear factor-kappa B (NF-κB) systems is associated with posttraumatic stress disorder in military personnel" [190] Psychological Stress IBD: "Acute psychological stress increases small intestinal permeability in humans.

Peripheral CRH reproduces the effect of stress and DSCG blocks the effect of both stress and CRH, suggesting the involvement of mast cells." [191] ID: "The authors examined whether psychological stress ... The stress from the academic examination significantly increased IL-1 beta, IL-6, and IL-10 and decreased IFN-gamma production. These findings suggest that examination stress may increase Th2 cell-mediated humoral immunity and macrophage activities and may decrease Th1 cell-mediated cellular immunity." [192] COV: "we evaluate preclinical and clinical literature suggesting that chronic stressinduced hyperinflammation interacts synergistically with COVID-19-related inflammation, contributing to a potentially fatal cytokine storm syndrome. In particular, we hypothesize that both chronic stress and COVID-19-related hyperinflammation are a product of glucocorticoid insufficiency. We discuss the devastating effects of SARS-CoV-2 on structural and functional aspects of the biological stress response and how these induce exaggerated inflammatory responses, particularly interleukin (IL)-6 hypersecretion. We postulate that chronic stress should be considered a significant risk factor for adverse COVID-19-related health outcomes, given overlapping peripheral and central immune dysregulation in both conditions." [193] Restraint Stress J o u r n a l P r e -p r o o f IBD: "we tested the hypothesis that cold-restraint stress would adversely effect the severity of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats, and examined mechanisms for the response. Results indicated that increasing intermittent prior exposures to stress significantly enhanced TNBS-induced colitis

severity. An associated stress-induced decrease in colonic mucin glycoprotein content, reduction in goblet cells, and histochemical mucin suggested reduced mucin was a pathogenetic factor." [194] ID: "Echinacea purpurea Protects Against Restraint Stress-Induced Immunosuppression in BALB/c Mice" [195] Sexual Abuse IBD: "However, subjects with irritable bowel syndrome reported much higher rates of childhood sexual abuse and psychosomatic symptoms." [196] ID: "Most studies reported an increase of inflammatory activity associated with the presence of early abuse. IL-6, TNF-α, and C-reactive protein were the most frequently analyzed markers and some studies showed higher levels in individuals that suffered CSA compared with controls," [197] J o u r n a l P r e -p r o o f Table 1 summarized the fifty validated CFs that were common to IBD and immune system dysfunction/COVID-19. Appendix 1 presented excerpts from the relevant references supporting the linkages between the CFs addressed and the diseases to which they contribute.

In this appendix, Table 1 COV Accumulation of advanced glycation end products; acute respiratory distress syndrome; atherothrombotic state; chronic inflammatory; cytokine storm; degrade tissue debris; exaggerated cytokine response; diabetes; impaired immune response; inflammatory response; increased metabolic activity; multi-organ failure; obesity; septic shock; tissue damage; viral infection [81] Alcoholism 1 IBD Crohn Disease (CD); inflammatory bowel disease (IBD); ulcerative colitis (UC) [ 

Communicable Diseases are not Communicable! Georgia Institute of Technology

The under-reported role of toxic substance exposures in the COVID-19 pandemic

Vaccine-and natural infection-induced mechanisms that could modulate vaccine safety

Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease

COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence

The role of toxic stimuli combinations in determining safe exposure limits

Prevention and reversal of Alzheimer's disease: treatment protocol. Georgia Institute of Technology

Literature-related discovery and innovation: Chronic kidney disease

Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China

Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a J o u r n a l P r e -p r o o f retrospective, multi-centre case series. Qjm-an

Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

Current global trends in the incidence of pediatric-onset inflammatory bowel disease

Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies

New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways

Effect of IBD medications on COVID-19 outcomes: results from an international registry

COVID-19 pandemic and alcohol consumption: Impacts and

RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?

SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?

COVID-19 and Diabetes: The Importance of Controlling RAGE

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes

The Inflammasome in Times of COVID-19

Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement

Inflammasome formation in the lungs of patients with fatal COVID-19

Accumulation and effects of dietary advanced glycation end products on the gastrointestinal tract in rats

Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages

Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle. Front Endocrinol (Lausanne)

Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study

Crohn's disease

Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia

CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

Environmental exposures and the risk of inflammatory bowel disease: a case-control study from Saudi Arabia

Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine

Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease

Oxidative injury and its defense system in vivo

Non-coplanar PCBmediated modulation of human leukocyte phagocytosis: A new mechanism for immunotoxicity

The role of interleukin family in perfluorooctanoic acid (PFOA)-induced immunotoxicity

Severity of COVID-19 at elevated exposure to perfluorinated alkylates

Smoking and alimentary diseases

Immunosuppression by Polycyclic Aromatic-Hydrocarbons -A Structure-Activity Relationship in B6c3f1 and Dba

Effects of air pollutants on the transmission and severity of respiratory viral infections

Risks of developing ulcerative colitis and Crohn's disease in relation to silica dust exposure in Sweden: a case-control study

Silica dust exposure induces autophagy in alveolar macrophages through switching Beclin1 affinity from Bcl-2 to PIK3C3

COVID-19: a new burden of respiratory disease among South African miners?

NTP toxicity studies of sodium dichromate dihydrate (CAS No. male BALB/c and am3-C57BL/6 mice

Inhalation Effects on Alveolar Macrophages and Immune Functions in Wistar Rats

Urinary trace elements in association with disease severity and outcome in patients with COVID-19

Acute high-dose titanium dioxide nanoparticle exposure alters gastrointestinal homeostasis in mice

Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder

Altered gene expression of the innate immune, neuroendocrine, and nuclear factor-kappa B (NF-kappa B) systems is associated with posttraumatic stress disorder in military personnel

Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism

Psychological stress may induce increased humoral and decreased cellular immunity

Does inflammation link stress to poor COVID-19 outcome? Stress Health

Reduction of colonic mucus by repeated shortterm stress enhances experimental colitis in rats

Echinacea purpurea Protects Against Restraint Stress-Induced Immunosuppression in BALB/c Mice

Childhood sexual abuse and psychosomatic symptoms in irritable bowel syndrome

Childhood Sexual Abuse and Indicators of Immune Activity: A Systematic Review

IL-8; intestinal epithelial barrier integrity

pro-inflammatory transcription factors; UC; zonula occludens

ID Ccl2; Ccl7; Cxcl1; Cxcl2; inflammatory secretome; leukocyte; macrophages

IBD Colon cancer; colon tumorigenesis; colonic inflammation; IBD; intestinal barrier function

ID Colon cancer; colon tumorigenesis; colonic inflammation; IBD; intestinal barrier function

High-fat diet 1 IBD Cholesterol; colitis; colonic epithelial cells; colonic inflammation; free fatty acids; gp91

IBD; lamina propria cells; MLCK tight junction; mucosal barrier permeability

mucosal oxidative stress; mucosal proinflammatory cytokines

ID Gut-associated lymphoid tissue; IBD

lamina propria lymphocytes; lipotoxicity

immunosilent/immunoinhibitory bacteroidetes LPS

lipopolysaccharide (LPS); oxidative stress

High-salt diet 1 IBD activated peritoneal macrophages

IL-6

lamina propria mononuclear cells; macrophages; mesenteric lymph node

mouse inducible nitric oxide synthase

peritoneal macrophage inflammation; proinflammatory; SGK1; spleen; TGF-β

ATP-induced currents; bacterial translocation; colonic inflammation; connexin43 (Cx43); enteric glia; IL-1β mRNA; IL-6; leaky gut

P2X7; purinergic P2X receptor activity

AP-1; bone marrowderived macrophages; CREB; innate immunity; microglia; microRNA-124; NF-κB p65; pain

Oral contraceptives 2 IBD UC [118] ID Autoimmune diseases; blood urea nitrogen; cytokines; glomerular immune complex deposition; immune system; kidney disease; proteinuria

Radiotherapy 2 IBD Bloating/distension; chronic gastrointestinal symptoms; fecal incontinence; flatulence; frequency; loose stool

ID Blood proteome; inflammatory responses [121] COV Cancer; carcinoma; COVID-19 [122] Renal transplantation 2 IBD Diarrhea; diverticular colon disease; fecal occult blood

HBoV-3; immunosuppressed; RVA

Rotavirus A (RVA) and Human Bocavirus (HBoV) in fecal samples

COV Chronic kidney disease

CD; granulomas; granulomas; ileocolitis; inflammation; inflammation; ulceration

IFN-γ; IgE; IL-2; infectious diseases; macrophages; monocytes

Th1/Th2 cell polarization

ZEN concentrations

IFN-γ; IgE; IL-2; infectious diseases; macrophages; monocytes

Th1/Th2 cell polarization

IBD Epithelial cells; immune activation; intestinal microbiota

ID IgG; IgM; monocytes; red blood cells

Aluminum 4 IBD Colitis

epithelial cell renewal; granuloma formation; immune toxicity; inflammatory cytokines expression; intestinal barrier function

+) cells

IL-2; immunotoxicity; splenic iron; splenic zinc

Benzene 4 IBD Abdominal pain; bloody diarrhea; CD11b+ cell infiltration; colonic migrating motor complex frequency and amplitude; cramping

IL-1β concentrations; inflammation; innate immune activation

Benzo(a)pyrene 4 IBD Colonic mucosa; gut microbiota dysbiosis

Th1/Th17 inflammation

2; GPR30; infection; membrane-bound oestrogen receptor; nuclear oestrogen receptors; nuclear receptor oestrogen-related receptor gamma

Cadmium 4 IBD Bacteria-induced cytokine responses

gastrointestinal autoimmune diseases; IBD; intestinal inflammation

ID Apoptosis induction; glutathione; IgEmediated histamine release; immunotoxic

innate immune system; macrophages; mast cells; nitrite production

COV Adaptive immunity; airway inflammation; apoptosis; barrier function; immunotoxicity; mucociliary clearance

Chlorpyrifos 4 IBD Chronic inflammation; colon weights; haptoglobin; immune tolerance

Treg-related genes

ID Immune response; oxidative stress; ROS [156] Fluoridated water 4 IBD Gut microbiota; intestinal inflammation [157] ID Catalase; cellular immunity; humoral immunity; immunotoxicity; MDA; monocytes; neutrophils; oxidative stress

plasma IgG; spleen

COV Airway inflammation; apoptosis; immunotoxicity; impaired mucociliary clearance; influenza; oxidative stress; reduced barrier function; respiratory diseases (COPD, bronchitis); respiratory dysfunction

IBD Dysbiosis; gut epithelium; gut's epithelial permeability; immune cell toxicity; immune response; inflammatory intestinal balance

ID Dysbiosis; gut epithelium; gut's epithelial permeability; immune cell toxicity; immune response; inflammatory intestinal balance

Nickel 4 IBD Metal hypersensitivity; T-cells

ID Apoptosis; cytokines; development of immune organs; immunoglobulins; immunotoxicity; immunotoxicological; inflammation; inflammation; lymphocyte; macrophages; natural killer cells; nuclear factor-κB; MAPK pathways; T and B lymphocytes

ID Apoptosis; apoptosis of lymphocytes; immunotoxicity; memory cells; memory immune response; number of effector and memory lymphocytes; primary immune response; secondary immune response; serum total IgG; serum anti-KLH IgG and KLH-responsive CD4 T cells and B cells

IBD Catalase; free radical production

high-molecular-weight antioxidants; lowmolecular-weight antioxidants; lymphocytes; neutrophils

IBD CD; PFAS serum levels; PFOS serum levels

myeloid differentiation 88; P65 transcription factor; pro-inflammatory cytokine IL-1β; spleen

IL-4

IL-8; immune cell recruiting; irak4; lipid peroxidation; myd88

NF-κB; NO; NO synthase gene; oxidative damage; oxidative stress; SOD; TNF-α; total antioxidant capacity expression

Turpentine 4 IBD Colonic distension

ID Dysregulation of genes

Psychological stress 5 IBD Intestinal permeability; mast cells activation

immune cell populations; immune function; macrophage; Th1 cell-mediated cellular immunity; Th2 cell-mediated humoral immunity and macrophage activities

COV Cytokine storm; diabetes; glucocorticoid insufficiency; hyperinflammation; hyperinflammatory responses; hypertension

IBD Colonic mucin glycoprotein

mast cell counts; mucin; myeloperoxidase content

IL-6; immunosuppression; splenic natural killer cell activity

IL-6; inflammatory activity

Paraquat IBD: "catabolism of cysteine by gut microbiota can release high levels of sulfide that may underlie the development or relapse of ulcerative colitis ... results suggest that sulfide toxicity is mediated by reactive oxygen species (ROS) ... sub-toxic levels of the superoxide generator paraquat can also increase the tolerance of worms to sulfide. Therefore, it appears that activation of ROS detoxification pathway prior to the exposure to sulfide, can increase the tolerance to sulfide toxicity." [164] ID:"treatment with 20 mg/kg PQ increased apoptosis of late stage effector cells to yield less memory cells and thereafter impair memory immune response," [165] PCBs (Polychlorinated Biphenyls)IBD: "We and other researchers verified that excessively produced free radicals by neutrophils induce various diseases such as Behçet's disease, MCLS, SLE (neutrophil-stimulated lymphocytes), RA (synovial fluid neutrophils), Crohn's disease, colitis ulcerosa, and dermatitis herpetiformis (Dühring). ... It was also found that PCB, methyl-Hg and Mn, Cd induce neuropathic diseases through the increase in free radical production." [166] ID: "Mixture and concentration-response experiments demonstrated a suppression of phagocytosis by non-coplanar PCBs suggesting a previously unrecognized aryl hydrocarbon receptor (AhR)-independent pathway. ... Our results are cause for concern as they suggest an AhR-independent pathway through which noncoplanar PCBs modulate phagocytosis, the immune system's first line of defense, possibly increasing the risk to developing infectious disease." [167] PFOA (Perfluorooctanoic Acid)IBD: "we found a strong positive exposure-response relation between PFOA serum levels and subsequent ulcerative colitis (UC) in a high-exposed population from the mid-Ohio valley" [168] COV